Úvod: Vztah sebestigmatizace a účinnosti léčby je u pacientů s poruchami neurotického spektra málo prozkoumán. Cílem práce bylo zjistit u těchto pacientů míru internalizovaného stigmatu a vztah internalizovaného stigmatu k míře naděje, strategiím zvládání stresu, osobnostním charakteristikám, míře disociace a léčebnému efektu intenzivního 6týdenního psychoterapeutického programu kombinovaného s farmakoterapií. Metoda: Do studie bylo zařazeno 32 pacientů obou pohlaví přijatých na psychoterapeutické oddělení k šestitýdennímu psychoterapeutickému pobytu. Na začátku léčby byly pacientům administrovány sebeposuzující dotazníky: TCI-R (Dotazník temperamentu a charakteru), ADHS (Dispoziční škála naděje), Cope Inventory, DES (Stupnice disociativní zkušenosti) a ISMI (Internalizované stigma psychické poruchy). Pro hodnocení závažnosti úzkostných příznaků byly na počátku a konci léčby použity posuzovací stupnice: CGI (Celkový klinický dojem), BAI (Beckův úzkostný inventář), BDI (Beckův depresivní inventář) a sebeposuzující SubjCGI (Subjektivní celkový klinický dojem). Všichni pacienti zařazení do sledování podstoupili celkem třicet 90minutových skupinových terapii a užívali psychofarmaka ve standardních terapeutických dávkách. Výsledky: V průběhu psychoterapeutického pobytu se u pacientů významně snížila průměrná míra depresivních příznaků a zlepšil se jejich celkový duševní stav. Celková míra sebestigmatizace přímo úměrně korelovala v dotazníku Cope Inventorys položkami tendence k užívání návykových látek a sklonem k rezignaci, a negativně se schopností plánovat řešení stresující situace. Z osobnostních charakteristik celková míra sebestigmatizace negativně korelovala s cílesměrností. Míra sebestigmatizace také statisticky signifikantně pozitivně korelovala s mírou disociativních příznaků, úzkostí na konci léčby a stupněm deprese na počátku i konci léčby. Míra internalizovaného stigmatu negativně korelovala se zlepšením celkového klinického dojmu posuzovaného lékařem. Závěr: Míra sebestigmatizace může významně souviset s některými osobnostními rysy a způsoby zvládání stresu u poruch neurotického spektra. Internalizované stigma také významně negativně ovlivňuje efektivitu kombinované psychoterapeutické a farmakoterapeutické léčby.

Introduction: Little is known about the relationship between self-stigma and treatment effect in patients with neurotic disorders. The goal of this research was to identify a level of internalized stigma in these patients and to clarify the relationship between self-stigma and hope, coping strategies, personality traits, and dissociation. Method: 32 patients absolved six week residential psychotherapeutic program in the psychotherapeutic department of the University Hospital in Olomouc. They were assessed by several scales - CGI (Clinical Global Impression), subjCGI (subjective CGI), BAI (Beck Anxiety Scale) and BDI (Beck Depression Scale). The patients also completed TCI-R (Temperament and Character Inventory), ADHS (Adult Dispositional Hope Scale), Cope Inventory, DES (Dissociative Experience Scale) and ISMI (Internalized Stigma of Mental Illness) at the start of the treatment. The treatment consisted of daily group therapy and pharmacotherapy in usual therapeutic doses. Results: There was a significant reduction of patients' depressive symptoms and improvement of their overall mental health (measured by subjective and objective CGI) during the hospitalization. The level of internalized stigma positively correlated with subscales substance use and tendencies to give up when confronted with stress of the Cope Inventory questionnaire. On the other hand, self-stigma was significantly negatively connected to self-directedness, pathway thinking (a part of Snyders concept of hope), an ability to plan solutions of stressful events and an ability to find positive elements in them in order to support inner growth. Internalized stigma was also significantly associated with a degree of dissociative symptoms, anxiety at the end of the treatment, and depression at the beginning and the end of the treatment. Self-stigma also negatively correlated with the improvement of the overall clinical evalution by a psychiatrist. Conclusion: Internalized stigma is an important factor which influences effectiveness of a combined psychotherapeutic and pharmacological treatment of patients with neurotic disorders.

• Klíčová slova
• sebestigmatizace, disociace,
• MeSH
• adaptace psychologická MeSH
• depresivní poruchy farmakoterapie   psychologie   MeSH
• dospělí MeSH
• duševně nemocní * psychologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• naděje MeSH
• neurotické poruchy farmakoterapie   psychologie   MeSH
• osobnostní dotazník statistika a číselné údaje   MeSH
• poruchy osobnosti farmakoterapie   psychologie   MeSH
• psychoterapie MeSH
• sebepojetí MeSH
• společenské stigma MeSH
• úzkostné poruchy farmakoterapie   psychologie   MeSH
• výsledek terapie * MeSH
• výsledky a postupy - zhodnocení (zdravotní péče) statistika a číselné údaje   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH

INTRODUCTION: Treatment adherence is one of the main factors affecting the success of treatment and, secondarily, the quality of life and social adaptation of the patients. The aim of this study was to investigate the association between self-stigmatization, treatment adherence and history of discontinuation of drug treatment. METHODS: The cross-sectional study was conducted on 120 (98 completed all the questionnaires) neurotic outpatients treated in the University Hospital Olomouc. The following variables were evaluated: the objective and subjective Clinical Global Impression (CGI) scale, Drug Attitude Inventory (DAI-10) questionnaire measuring adherence, Internalized Stigma of Mental Illness (ISMI) scale measuring self-stigma, and a demographic data questionnaire. RESULTS: Data analysis showed no correlation between self-stigmatization and age, age of onset or length of the post-hospitalization phase. However, there were significant correlations between self-stigmatization and the severity of the disorder (assessed by both objective and subjective CGI), number of previous hospitalizations, total number of psychiatrists visited by the patient, the arbitrary discontinuation of medication in the past, and the dose of an antidepressant. Furthermore, self-stigma was significantly negatively correlated with the current treatment adherence. The rate of adherence was negatively correlated with both objective and subjective CGI only. CONCLUSIONS: Self-stigma significantly affects the current adherence to the treatment of neurotic spectrum disorders.

• MeSH
• adherence k farmakoterapii psychologie   MeSH
• antidepresiva terapeutické užití   MeSH
• anxiolytika terapeutické užití   MeSH
• dospělí MeSH
• kvalita života psychologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• průřezové studie MeSH
• průzkumy a dotazníky MeSH
• sebepojetí * MeSH
• společenské stigma * MeSH
• úzkostné poruchy farmakoterapie   psychologie   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH

BACKGROUND: Much attention has been paid to psychological factors influencing characteristics, severity, and course of mental disorders. The objective of our investigation was to examine the interrelations among quality of life (QoL), self-stigma, and coping strategies, demographics and severity of the disorder in neurotic spectrum disorders, schizophrenia, and depressive spectrum disorders. METHODS: A total of 343 clinically stable Czech outpatients with different mental disorders (153 with neurotic spectrum disorders; 81 with depression, and 109 with schizophrenia spectrum disorders) were included. The patients were examined by their outpatient psychiatrists during regular psychiatric checkup and completed a sociodemographic questionnaire, the Quality of Life Satisfaction and the Enjoyment Questionnaire (Q-LES-Q), the Internalized Stigma of Mental Illness Scale (ISMI), the Stress Coping Style Questionnaire (SVF-78), and the Clinical Global Impression scale (CGI). RESULTS: The study demonstrates that the self-stigma and coping strategies are significant factors linked to the QoL in all diagnostic groups of patients. Patients with schizophrenia spectrum disorders had lower scores in QoL compared to the other two groups. The patients with depression or neurotic spectrum disorders had a lesser degree of self-stigma than the patients with schizophrenia spectrum disorders. The severity of the illness significantly correlated with the QoL, self-stigma, and coping strategies. CONCLUSIONS: The investigation confirmed the connection between the quality of life, self-stigma, coping strategies, and the severity of the illness, in outpatients with schizophrenia spectrum disorders, depressive, and neurotic spectrum disorders. A further longitudinal study would be useful to determine the causative relationships of these variables.

• MeSH
• adaptace psychologická * MeSH
• depresivní poruchy psychologie   MeSH
• dospělí MeSH
• duševní poruchy psychologie   MeSH
• kvalita života psychologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• neurotické poruchy psychologie   MeSH
• pacienti ambulantní MeSH
• průřezové studie MeSH
• psychotické poruchy psychologie   MeSH
• schizofrenie (psychologie) MeSH
• schizofrenie MeSH
• sebepojetí * MeSH
• společenské stigma * MeSH
• stupeň závažnosti nemoci MeSH
• úzkostné poruchy psychologie   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH

AIMS: To measure the stigma of healthcare providers toward people suffering from mental illness, the Opening Minds Stigma Scale for Health Care Providers (OMS-HC) is a commonly applied instrument. However, this scale has not been thoroughly validated in many European countries, its psychometric properties are still unknown and data on practicing psychiatrists is lacking. Therefore, this multicenter study aimed to assess the psychometric characteristics of the 15-item OMS-HC in trainees and specialists in adult and child psychiatry in 32 countries across Europe. MATERIALS AND METHODS: The OMS-HC was conducted as an anonymous online survey and sent via Email to European adult and child psychiatrists. Parallel analysis was used to estimate the number of OMS-HC dimensions. Separate for each country, the bifactor ESEM, a bifactor exploratory structural equation modeling approach, was applied to investigate the factor structure of the scale. Cross-cultural validation was done based on multigroup confirmatory factor analyses and reliability measures. RESULTS: A total of 4,245 practitioners were included, 2,826 (67%) female, 1,389 (33%) male. The majority (66%) of participants were specialists, with 78% working in adult psychiatry. When country data were analyzed separately, the bifactor model (higher-order factor solution with a general factor and three specific factors) showed the best model fit (for the total sample χ2/df = 9.760, RMSEA = 0.045 (0.042-0.049), CFI = 0.981; TLI = 0.960, WRMR = 1.200). The average proportion of variance explained by the general factor was high (ECV = 0.682). This suggests that the aspects of 'attitude,' 'disclosure and help-seeking,' and 'social distance' could be treated as a single dimension of stigma. Among the specific factors, the 'disclosure and help-seeking' factor explained a considerable unique proportion of variance in the observed scores. CONCLUSION: This international study has led to cross-cultural analysis of the OMS-HC on a large sample of practicing psychiatrists. The bifactor structure displayed the best overall model fit in each country. Rather than using the subscales, we recommend the total score to quantify the overall stigmatizing attitudes. Further studies are required to strengthen our findings in countries where the proposed model was found to be weak.

• MeSH
• dítě MeSH
• dospělí MeSH
• lidé MeSH
• postoj zdravotnického personálu * MeSH
• psychometrie MeSH
• reprodukovatelnost výsledků MeSH
• společenské stigma * MeSH
• zdravotnický personál MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• práce podpořená grantem MeSH

Úvod: Stigma duševní nemoci je komplexní psychosociální jev, který má mnoho negativních dopadů na život, včetně snížení jeho kvality. Vede k odkládání potřebné léčby, komplikuje ji a snižuje její výsledky se všemi psychosociálními dopady. Výzkum rozlišuje vnější stigmatizaci a sebestigmatizaci. Sebestigmatizace internalizuje stigmatizující postoje a vede k rozvoji maladaptivních životních strategií. Cílem práce bylo zjistit míru sebestigmatizace a její vztah k osobnostním rysům, závažnosti poruchy a demografickým faktorům u osob se schizofrenním onemocněním. Metoda: Do studie bylo zařazeno 39 ambulantních pacientů s diagnózou schizofrenie, schizoafektivní poruchy nebo trvalé poruchy s bludy, kteří byli ve stabilizovaném stavu. Všichni pacienti byli léčeni antipsychotiky K potvrzení diagnózy bylo použito strukturované interview M.I.N.I. (Mini International Neuropsychiatric Interview). Pro hodnocení sebestigmatizace byl použit sebepo-suzující dotazník ISMI (Škála internali-zovaného stigmatu psychické poruchy), pro míru naděje ADHS (Dispoziční škála naděje pro dospělé), pro hodnocení temperamentu a charakteru TCI-R (Revidovaný dotazník temperamentu a charakteru). Míra deprese byla hodnocena pomocí BDI-II (Beckův depresivní inventář) a míra úzkosti pomocí BAI (Beckův inventář úzkosti). Demografické údaje byly kompletovány pomocí demografického dotazníku. Samotná závažnost psychotické poruchy byla objektivně hodnocena pomocí CGI-O (Celkový klinický dojem-objektivní) a subjektivně pomocí CGI-S. Výsledky: Dle celkového skóre ISMI dosahovala průměrná míra sebestigmati-zace hodnoty 60,84 ? 12,24 bodu. Celkové skóre ISMI pozitivně korelovalo s celkovou závažností onemocnění v CGI-0 i CGI-S. Míra sebestigmatizace dle ISMI také pozitivně korelovala s osobnostním rysem HA (vyhýbání se ohrožení), délkou léčby a počtem hospitalizací, negativně korelovala s osobnostními rysy PS (persistence), SD (sebeřízení), CO (kooperace) a mírou naděje (dle ADHS). Mnohonásobná zpětná kroková regrese ukázala, že nejdůležitějšími nezávislými proměnnými, které se do míry sebestigmatizace promítají, jsou počet hospitalizací a míra HA (vyhýbání se ohrožení). Závěr: Ambulantní pacienti s diagnózou schizofrenního spektra s anamnézou vyššího počtu hospitalizací a rysem temperamentu Vyhýbání se ohrožení mají vysokou míru sebestigmatizace. Komplexní strategie vedoucí k redukci vyhýbavého chování a snížení počtu hospitalizací by mohla vést k snížení sebestigmatizace a jejích důsledků.

Introduction: A stigma of mental illness is a complex psychosocial phenomenon, which decreases the quality of life of the patients. It brings a number of negative psychosocial outcomes, leads to avoidance of proper treatment, and complicates the already started treatment. Often, it contributes to unsatisfactory therapeutic results. Self-stigma is based on inter-nalization of the stigmatizing beliefs. It results in a development of maladaptive coping strategies in the individuals with mental disorders. The relationship between personality traits and self-stigma has not been sufficiently scrutinized in the population of the patients with schizophrenia spectrum disorders. Thus, the goal of this paper was to explore the levels of self-stigma in this population and its relationship to personality traits, the severity of the psychotic disorder, and demographic factors. Method: Participation in the study was offered to patients diagnosed with schizophrenia spectrum disorders (schizophrenia, schizoaffective disorder, delusional disorder), who were regularly attending a psychiatry department outpatient center and were stabilized during the study. 39 participants of both sexes participated in the study. All patients were using antipsychotics. The Mini International Neuropsychiatric Interview was performed to refine the diagnostics. The patients then completed these psychodiagnostic methods: The ISMI Scale (The Internalized Stigma of Mental Illness Scale), ADHS (The Adult Dispositional Hope Scale), and TCI-R (The Temperament and Character Inventory - Revised). The psychiatrist assessed the disorder severity by using CGI-O (The Clinical Global Impression - the objective version), and the patients completed a similar self-evaluation by using the subjective version of the scale (CGI-S). Each participant also completed BDI-II (The Beck Depression Inventory - II), measuring the severity of depressive symptoms, and BAI (The Beck Anxiety Inventory), measuring the severity of the anxiety symptoms. Results: The mean level of the self-stigma was 60.84 ? 12.24 (ISMI). The overall level of self-stigma positively correlated with the disorder severity measured by CGI-O and CGI-S. Furthermore, it was positively connected to Harm avoidance, the treatment duration, and the number of underwent psychiatric hospitalizations. The overall level of the self-stigma then significantly negatively correlated with several personality traits, namely Persistence, Self-directedness, and Cooperativeness, and with hope in ADHS. The backward stepwise regression was applied to identify the most significant factors connected to the self-stigma. The regression analysis showed Harm avoidance and the number of previous psychiatric hospitalizations as the most significant regressors. Conclusion: Outpatients with schizophrenia spectrum disorders, who show high levels of harm avoidance and/or have undergone a higher number of psychiatric hospitalizations, tend to experience more pronounced symptoms of self-stigma. Complex therapeutic strategies, aimed at reduction of the avoidant behavior and the potentially unnecessary hospitalizations, may serve as prevention against the development of the self-stigma and its negative consequences.

• MeSH
• adaptace psychologická MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• naděje MeSH
• osobnostní dotazník MeSH
• průřezové studie MeSH
• psychiatrické posuzovací škály MeSH
• psychologické testy MeSH
• psychotické poruchy MeSH
• regresní analýza MeSH
• schizofrenie * MeSH
• sebepojetí * MeSH
• sebezhodnocení (psychologie) MeSH
• stereotypizace * MeSH
• stupeň závažnosti nemoci MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH

• MeSH
• dospělí MeSH
• elektrokonvulzívní terapie * MeSH
• lékařství v umění MeSH
• lidé středního věku MeSH
• lidé MeSH
• mínění * MeSH
• mladý dospělý MeSH
• průzkumy a dotazníky MeSH
• psychiatrie v literatuře MeSH
• veřejné mínění MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• práce podpořená grantem MeSH

Goal: The goal of this study was to explore the impact of self-stigma on the treatment outcomes in patients with anxiety disorders and to find possible mediators of this relationship. Method: Two hundred and nine patients with anxiety disorders, who were hospitalized in a psychotherapeutic department, attended the study. The average age was 39.2±12.4 years; two-thirds were women. Most of the patients used a long-term medication. The participants underwent either cognitive behavioral therapy (CBT) or short psychodynamic therapy. The selection to the psychotherapy was not randomized. All individuals completed several scales - Beck Depression Inventory, the second edition (BDI-II), Beck Anxiety Inventory (BAI), Dissociative Experience Scale (DES), Sheehan Disability Scale (SDS), subjective Clinical Global Impression (subjCGI), and The Internalized Stigma of Mental Illness Scale (ISMI). A senior psychiatrist filled out the objective CGI (objCGI). Results: The patients significantly improved in the severity of anxiety (BAI), depression (BDI-II), and overall severity of the mental disorder (objCGI). The self-stigma predicted a lower change of the objCGI, but not a change of the anxiety and depressive symptoms severity. Anxiety, depressive symptoms, dissociation, and disability were assessed as possible mediators of the relationship between the self-stigma and the treatment change. None of them were significant. Conclusion: Self-stigma lowers the effectiveness of the combined treatment of anxiety disorders. Future research should explore other possible mediators influencing this relationship.

• Publikační typ
• časopisecké články MeSH

INTRODUCTION: Self-stigma plays a role in many areas of the patient's life. Furthermore, it also discourages therapy. The aim of our study was to examine associations between self-stigma and adherence to treatment and discontinuation of medication in patients from various diagnostic groups. METHODS: This cross-sectional study involved outpatients attending the Department of Psychiatry, University Hospital Olomouc, Czech Republic. The level of self-stigma was measured with the Internalized Stigma of Mental Illness and adherence with the Drug Attitude Inventory. The patients also anonymously filled out a demographic questionnaire which included a question asking whether they had discontinued their medication in the past. RESULTS: We examined data from 332 patients from six basic diagnostic categories (substance abuse disorders, schizophrenia, bipolar disorders, depressive disorders, anxiety disorders, and personality disorders). The study showed a statistically significant negative correlation between self-stigma and adherence to treatment in all diagnostic groups. Self-stigma correlated positively and adherence negatively with the severity of disorders. Another important factor affecting both variables was partnership. Self-stigma positively correlated with doses of antidepressants and adherence with doses of anxiolytics. Self-stigma also negatively correlated with education, and positively with a number of hospitalizations and number of psychiatrists visited. Adherence was further positively correlated with age and age of onset of disorders. Regression analysis showed that self-stigma was an important factor negatively influencing adherence to treatment and significantly contributing to voluntary discontinuation of drugs. The level of self-stigma did not differ between diagnostic categories. Patients suffering from schizophrenia had the lowest adherence to treatment. CONCLUSION: The study showed a significant correlation between self-stigma and adherence to treatment. High levels of self-stigma are associated with discontinuation of medications without a psychiatrist's recommendation. This connection was present in all diagnostic groups.

• Publikační typ
• časopisecké články MeSH

Stigmatizace lidí s duševním onemocněním představuje závažný problém zdravotnictví. Přispívá k jejich zhoršené zdravotní a preventivní péči, ke snížení jejich ochoty vyhledat odbornou pomoc, a snižuje tak kvalitu a průměrnou délku jejich života. Cílem studie je vyhodnotit efektivitu destigmatizační intervence READ v rámci psychiatrického modulu u studentů medicíny. Intervenci vedl psychiatr a peer lektor. Jedná se o součást mezinárodního projektu INDIGO. Studie se zúčastnilo celkem 53 studentů lékařské fakulty (32 v intervenční skupině, 21 v kontrolní). Respondenti vyplňovali dotazník měřící postoje, znalosti, empatii a meziskupinovou úzkost před účastí na intervenci READ a po ní. U intervenční skupiny došlo ke snížení stigmatizujících postojů, zvýšení znalostí a snížení meziskupinové úzkosti. Kontrolní skupina dosáhla v následném měření zvýšení znalostí a snížení meziskupinové úzkosti. Z výsledků lze vyvodit, že běžný psychiatrický modul (teorie a praxe na odděleních) na lékařské fakultě nemá dostatečný destigmatizační potenciál. Intervence READ se zapojením peer lektorů se zdá být vhodným nástrojem jak snižovat stigmatizaci lidí s duševním onemocněním na lékařských fakultách. Kontakt s lidmi, kteří již nejsou v akutní fázi duševního onemocnění, je klíčový pro snižování stigmatizace.

Stigmatization of people with mental illness in health care is a serious problem contributing to poor provision of health care and preventive medicine, it decreases their willingness to seek help and reduces quality of their life and life expectancy. The aim of this study is to evaluate the impact of the anti-stigma training READ on medical students during their psychiatric module. The training was held by a psychiatrist and a peer lecturer. This study is a part of the international project INDIGO. A total of 53 medical students participated in this study (32 in intervention group, 21 in control group). Participants completed questionnaire at baseline and at immediate follow-up. It contained scales measuring attitudes, knowledge, empathy and intergroup anxiety. The intervention group demonstrated reductions in stigma-related attitudes, improvements in mental illness knowledge and reductions in intergroup anxiety. At immediate follow-up the control group demonstrated improvements in mental illness knowledge and reductions in intergroup anxiety. Based on the results of this study common psychiatric module at the medical school (including theoretical and practical education) does not contribute to the sufficient reduction of stigma. The training READ with an involvement of peer lecturers appears to be a convenient instrument how to reduce stigmatization of people with mental illness at medical schools. The contact with people who are not in the acute state of the illness is crucial for destigmatization.

• MeSH
• duševně nemocní * psychologie   MeSH
• lidé MeSH
• postoj MeSH
• průzkumy a dotazníky MeSH
• společenské stigma MeSH
• studenti lékařství * psychologie   MeSH
• Check Tag
• lidé MeSH
• Geografické názvy
• Česká republika MeSH

BACKGROUND: Maladaptive coping strategies may adversely disturb the overall functioning of people with mental disorders. Also, self-stigma is considered a maladaptive psychosocial phenomenon that can affect many areas of patient life. It has a negative impact on self-image, and may lead to dysphoria, social isolation, reduced adherence, using of negative coping strategies, and lower quality of life. The objective of this study was to determine the relationship between coping strategies and self-stigma among persons with schizophrenia and related psychotic disorders. SUBJECTS AND METHODS: A total of 104 clinically stable outpatients with chronic schizophrenia-spectrum disorders were enrolled in a cross-sectional study. Sociodemographic and clinical data were recorded. Patients were examined by psychiatrists with the Stress Coping Style Questionnaire, the Internalized Stigma of Mental Illness scale, and the Clinical Global Impression scale. Correlation and multiple-regression analyses were performed to discover contributing factors to self-stigma. RESULTS: Positive coping strategies were used by patients with schizophrenia-spectrum disorders to the same extent as in the healthy population. Negative coping strategies were overused by these patients. There were significant associations between self-stigma, severity of the disorder, and coping strategies in schizophrenia. The ability to use positive coping strategies was connected with lower self-stigma. Use of negative coping strategies predominantly increased the self-stigma of patients with schizophrenia. CONCLUSION: This study revealed a significant association among self-stigma, severity of the disorder, and coping strategies in individuals suffering from schizophrenia-spectrum disorders. Thinking about coping strategies and self-stigma in practice may play a significant role in understanding people with schizophrenia-spectrum disorders, especially for mental health professionals.

• Publikační typ
• časopisecké články MeSH